1. Adem A, Jossan SS, Oreland L (1989) Tetrahydroaminoacridine inhibits human and rat brain monoamine oxidase. Neurosci Lett 107: 313–317
2. Adolfsson R, Gottfries C-G, Roos BE, Winblad B (1979) Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry 135: 216–223
3. Adolfsson R, Gottfries C-G, Oreland L, Wiberg A, Winblad B (1980) Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 27: 1029–1034
4. Åhlin A, Nybäck H, Junthe T, Öhman G, Nordgren I (1991) THA in Alzheimer's dementia: clinical, biochemical and pharmacokinetic findings. In: Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM (eds) Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies. Wiley, Chichester, pp 522–532
5. Alhainen K, Riekkinen P Sr, Helkala E-L, Partanen J, Laulumaa V, Reinikainen K, Soininen H, Airaksinen M (1991) The effect of THA on cognitive functions and spectral power EEG in Alzheimer's disease: preliminary results of an open study. In: Iqbal K, McLachlan DRC, Winblad B, Wisniewski HM (eds) Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies. Wiley, Chichester, pp 611–619